Verona Pharma (NASDAQ:VRNA) Price Target Raised to $107.00 at Wells Fargo & Company
Verona Pharma (NASDAQ:VRNA – Free Report) had its target price raised by Wells Fargo & Company from $93.00 to $107.00 in a report released on Wednesday morning,Benzinga reports. They currently have an overweight rating on the stock. VRNA has been the topic of a number of other research reports. Truist Financial reiterated a “buy” rating […]
Verona Pharma (NASDAQ:VRNA – Free Report) had its target price raised by Wells Fargo & Company from $93.00 to $107.00 in a report released on Wednesday morning,Benzinga reports. They currently have an overweight rating on the stock. VRNA has been the topic of a number of other research reports. Truist Financial reiterated a “buy” rating […]
-plc-logo-1200x675.JPG&w=240&h=240&zc=2){kind=logo}
